JOJully Oyama

Jully Oyama

*This is an algorithmically generated author record based on publicly available information.

Jully Oyama has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Therapeutic potential of medicinal plants and compounds in mitigating 5-fluorouracil-induced intestinal mucositis: a systematic review

    by Lilian Catarim Fabiano, Camila Alves Mota, Mariana Conceição da Silva, Karile Cristina da Costa Salomão, Débora Dei Tos, Fernanda Losi Alves de Almeida, Jully Oyama, Jorge Juarez Vieira Teixeira, Nilza Cristina Buttow

    The chemotherapy drug 5-fluorouracil (5-FU) is extensively utilised, however its its administration is extremely restricted due to its serious adverse effects, including intestinal mucositis, which can lead to the patient's death. Our objective was to identify plant options or derived utilised in the treatment of 5-FU-induced intestinal mucositis and their efficacy.The study used the Preferred Report Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 25 articles were selected from the databases and subjected to descriptive and bias analysis. A variety of medicinal plants or compounds were evaluated for their effects on intestinal mucositis triggered by 5-FU, but some stood out for more efficiently attenuating changes related to IM, including oxidative stress, inflammation, histology and clinical status of the animals. The data obtained could clarify and advance clinical trials. Treatment with medicinal plants can improve the quality of life of cancer patients undergoing chemotherapy with 5-FU.

  • Open Access

    In vitro effects of lapachol and β-lapachone against Leishmania amazonensis

    by Á.C.F.H. Ramos-Milaré, B.G. Sydor, A.á. Brustolin, D.S.S.L. Lera-Nonose, J. Oyama, E.L. Silva, W. Caetano, K.S.S. Campanholi, I.G. Demarchi, T.G.V. Silveira, et al.

    Leishmaniasis is a neglected disease that affects millions of people worldwide, and special attention should be given to treatment because the available drugs have limitations, which can lead to low therapeutic adherence and parasitic resistance. This study evaluated the activity of the bioactive naphthoquinones, lapachol and β-lapachone, against Leishmania amazonensis. The cell alterations were evaluated in vitro on promastigote and amastigote forms. The lethal dose (LD50) at 24, 48, and 72 h on the promastigote's forms using lapachol was 75.60, 72.82, and 58.85 μg/mL and for β-lapachone was 0.65, 1.24, and 0.71 μg/mL, respectively. The naphthoquinones significantly inhibited the survival rate of L. amazonensis amastigotes at 83.11, 57.59, and 34.95% for lapachol (82.28, 41.14, and 20.57 µg/mL), and 78.49, 83.25, and 80.22% for β-lapachone (3.26, 1.63, and 0.815 µg/mL). The compounds on the promastigote's forms led to the loss of mitochondrial membrane potential, induced changes in the integrity of the membrane, caused damage to cells suggestive of the apoptotic process, and showed inhibition of tumor necrosis factor (TNF)-α and interleukin (IL)-6 production. The results showed that these naphthoquinones are promising candidates for research on new drugs with anti-Leishmania activity derived from natural products.


  • Three Decades of Clinical Trials on Immunotherapy for Human Leishmaniases: a Systematic Review and Meta-Analysis

    by Camila Alves Mota, Jully Oyama, Mariana de Souza Terron Monich, Aline Ávila Brustolin, João Vítor Perez de Souza, Letícia Sayuri Murase, Luciana Dias Ghiraldi Lopes, Thais da Silva Santos, Jorge Juarez Vieira Teixeira, Thaís Gomes Verzignassi Silveira

    Aim: Current treatments for leishmaniases are not satisfactory, thus alternatives are needed. We searched for clinical trials with immunotherapeutic approaches for patients with leishmaniasis. Mate...


  • Effect of essential oils on Leishmania amazonensis: a systematic review

    by Célia Eliane de Lara da Silva, Jully Oyama, Fabiana Borges Padilha Ferreira, Marielle Priscila de Paula Silva, Tarcísio Vitor Augusto Lordani, Rogério Cesar de Lara da Silva, Mariana de Souza Terron Monich, Jorge Juarez Vieira Teixeira, Maria Valdrinez Campana Lonardoni

    This systematic review investigated the evidence for the therapeutic potential of essential oils (EOs) against Leishmania amazonensis. We searched available scientific publications from 2005 to 2019 in the PubMed and Web of Science electronic databases, according to PRISMA statement. The search strategy utilized descriptors and free terms. The EOs effect of 35 species of plants identified in this systematic review study, 45.7% had half of the maximal inhibitory concentration (IC50) 10 < IC50 ⩽ 50 μg mL−1 and 14.3% had a 10 < IC50μg mL−1 for promastigote forms of L. amazonensis. EOs from Cymbopogon citratus species had the lowest IC50 (1.7 μg mL−1). Among the plant species analyzed for activity against intracellular amastigote forms of L. amazonensis, 39.4% had an IC50 10 < IC50 ⩽ 50 μg mL−1, and 33.3% had an IC50 10 < IC50μg mL−1. Aloysia gratissima EO showed the lowest IC50 (0.16 μg mL−1) for intracellular amastigotes. EOs of Chenopodium ambrosioides, Copaifera martii and Carapa guianensis, administered by the oral route, were effective in reducing parasitic load and lesion volume in L. amazonensis-infected BALB/c mice. EOs of Bixa orellana and C. ambrosioides were effective when administered intraperitoneally. Most of the studies analyzed in vitro and in vivo for the risk of bias showed moderate methodological quality. These results indicate a stimulus for the development of new phytotherapy drugs for leishmaniasis treatment.


  • Photodynamic therapy in wound healing in vivo: a systematic review

    by Jully Oyama, Áquila Carolina Fernandes Herculano Ramos-Milaré, Daniele Stéfanie Sara Lopes Lera-Nonose, Vanessa Nesi-Reis, Izabel Galhardo Demarchi, Sandra Mara Alessi Aristides, Jorge Juarez Vieira Teixeira, Thaís Gomes Verzignassi Silveira, Maria Valdrinez Campana Lonardoni


  • Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy

    by Jully Oyama, Daniele Stéfanie Sara Lopes Lera-Nonose, Áquila Carolina Fernandes Herculano Ramos-Milaré, Fabiana Borges Padilha Ferreira, Camila Fabiano de Freitas, Wilker Caetano, Noboru Hioka, Thaís Gomes Verzignassi Silveira, Maria Valdrinez Campana Lonardoni


  • Top Cited Papers

    Contribution of photodynamic therapy in wound healing: A systematic review

    by Vanessa Nesi-Reis, Daniele Stéfanie Sara Lopes Lera-Nonose, Jully Oyama, Marielle Priscila Paula Silva-Lalucci, Izabel Galhardo Demarchi, Sandra Mara Alessi Aristides, Jorge Juarez Vieira Teixeira, Thaís Gomes Verzignassi Silveira, Maria Valdrinez Campana Lonardoni


  • Open Access

    American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case

    by Jully Oyama, Fabiana Borges Padilha Ferreira, Carolina Cella Conter, Daniele Stéfanie Sara Lopes Lera-Nonose, Áquila Carolina Fernandes Herculano Ramos-Milaré, Eneide Aparecida Sabaini Venazzi, Thaís Gomes Verzignassi Silveira, Maria Valdrinez Campana Lonardoni

    This clinical case presents a patient with a raised and ulcerative lesion with erythematous edges in the mouth, on the lower lip that was unsuccessfully treated as herpes labialis. Clinical data and laboratory tests (Montenegro skin test, indirect immunofluorescence, direct parasite search and polymerase chain reaction) led to the diagnosis of American tegumentary leishmaniasis caused by Leishmania (Viannia) sp. Treatment with pentavalent antimonial (Glucantime®) for 120 days was not effective and administration of amphotericin B for 30 days resulted in wound healing. Glucantime® treatment protocol was longer than the recommended by the Brazilian Ministry of Health in the handbook of mucosal leishmaniasis. This suggests that amphotericin B should have been administered earlier, preventing the psychological and social problems faced by the patient. This study reports a rare clinical case of primary mucosal leishmaniasis on the lip that had a delayed diagnosis, highlighting the precariousness in the management of disease and showing that, despite the importance of leishmaniasis in Brazil, it is still neglected by health professionals.


  • Qualidade microbiológica da água para consumo humano em instituição de ensino de Maringá-PR

    by Mirian Ueda Yamaguchi, Lúcia Elaine Ranieri Cortez, Lilian Cristina Camargo Ottoni, Jully Oyama